Navtemadlin and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma
Clinical trial NCT03217266 · COMPLETED
Trial details
- NCT number
- NCT03217266
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-20
- Primary completion
- 2023-08-27
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.